According to the latest equity disclosure information from the Hong Kong Stock Exchange, the board of directors of Consun Pharma (01681.HK) learned that Chairman An Meng increased his shareholding by 0.123 million shares, 0.05 million shares, and 1.3 million shares at an average price of HKD 5.61, 5.73, and 5.9 respectively on July 3-5, 2024, with a total of 1.473 million shares and a total amount of approximately HKD 8.6465 million. After the shareholding increase, An Meng's latest holding is 0.213 billion shares, with a latest shareholding ratio of 25.26%.
Market analysts believe that this demonstrates his firm confidence in the future development prospects of the company.
